Effect of haemodiafiltration vs conventional haemodialysis on growth and cardiovascular outcomes in children - the HDF, heart and height (3H) study

. 2018 Aug 10 ; 19 (1) : 199. [epub] 20180810

Jazyk angličtina Země Anglie, Velká Británie Médium electronic

Typ dokumentu klinické zkoušky, srovnávací studie, časopisecké články, multicentrická studie, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid30097064
Odkazy

PubMed 30097064
PubMed Central PMC6086045
DOI 10.1186/s12882-018-0998-y
PII: 10.1186/s12882-018-0998-y
Knihovny.cz E-zdroje

BACKGROUND: Cardiovascular disease is prevalent in children on dialysis and accounts for almost 30% of all deaths. Randomised trials in adults suggest that haemodiafiltration (HDF) with high convection volumes is associated with reduced cardiovascular mortality compared to high-flux haemodialysis (HD); however paediatric data are scarce. We designed the haemodiafiltration, heart and height (3H) study to test the hypothesis that children on HDF have an improved cardiovascular risk profile, growth and nutritional status and quality of life, compared to those on conventional HD. We performed a non-randomised parallel-arm intervention study within the International Paediatric Haemodialysis Network Registry comparing children on HDF and conventional HD to determine annualised change in cardiovascular end-points and growth. Here we present the 3H study design and baseline characteristics of the study population. METHODS: 190 children were screened and 177 (106 on HD and 71 on HDF) recruited from 28 centres in 10 countries. There was no difference in age, underlying diagnosis, comorbidities, previous dialysis therapy, dialysis vintage, residual renal function, type of vascular access or blood flow between HD and HDF groups. High flux dialysers were used in 63% of HD patients and ultra-pure water was available in 52%. HDF patients achieved a median convection volume of 13.3 L/m2; this was associated with the blood flow rate only ((p = 0.0004, r = 0.42) and independent of access type (p = 0.38). DISCUSSION: This is the largest study on dialysis outcomes in children that involves deep phenotyping across a wide range of cardiovascular, anthropometric, nutritional and health-related quality of life measures, to test the hypothesis that HDF leads to improved cardiovascular and growth outcomes compared to conventional HD. TRIAL REGISTRATION: ClinicalTrials.gov: NCT02063776 . The trial was prospectively registered on the 14 Feb 2014.

Zobrazit více v PubMed

US Renal Data System U2Adr . Atlas of chronic kidney disease and end-stage renal disease in the United States. 2011.

Shroff R, Long DA, Shanahan C. Mechanistic insights into vascular calcification in CKD. J Am Soc Nephrol. 2013;24:179–189. doi: 10.1681/ASN.2011121191. PubMed DOI

Mitsnefes MM, Kimball TR, Kartal J, Witt SA, Glascock BJ, Khoury PR, et al. Cardiac and vascular adaptation in paediatric patients with chronic kidney disease: role of calcium-phosphorus metabolism. J Am Soc Nephrol. 2005;16:2796–2803. doi: 10.1681/ASN.2005030291. PubMed DOI

Shroff RC, McNair R, Figg N, Skepper JN, Schurgers L, Gupta A, et al. Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation. 2008;118:1748–1757. doi: 10.1161/CIRCULATIONAHA.108.783738. PubMed DOI

Litwin M, Wuhl E, Jourdan C, Niemirska A, Schenk JP, Jobs K, et al. Evolution of large-vessel arteriopathy in paediatric patients with chronic kidney disease. Nephrol Dial Transplant. 2008;23:2552–2557. doi: 10.1093/ndt/gfn083. PubMed DOI

Agbas A, Canpolat N, Caliskan S, Yilmaz A, Ekmekci H, Mayes M et al.. Haemodiafiltration is associated with reduced inflammation, oxidative stress and improved endothelial risk profile compared to high-flux haemodialysis in children. PLoS.One. In press. 2018. PubMed PMC

Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, et al. Effect of dialysis dose and membrane flux in maintenance haemodialysis. N Engl J Med. 2002;347:2010–2019. doi: 10.1056/NEJMoa021583. PubMed DOI

Blankestijn PJ, Ledebo I, Canaud B. Haemodiafiltration: clinical evidence and remaining questions. Kidney Int. 2010;77:581–587. doi: 10.1038/ki.2009.541. PubMed DOI

Ledebo I, Blankestijn PJ. Haemodiafiltration-optimal efficiency and safety. NDT Plus. 2010;3:8–16. PubMed PMC

Mostovaya IM, Grooteman MP, Basile C, Davenport A, de Roij van Zuijdewijn CL, Wanner C, et al. High convection volume in online post-dilution haemodiafiltration: relevance, safety and costs. Clin Kidney J. 2015;8:368–373. doi: 10.1093/ckj/sfv040. PubMed DOI PMC

Maduell F, Moreso F, Pons M, Ramos R, Mora-Macia J, Carreras J, et al. High-efficiency postdilution online haemodiafiltration reduces all-cause mortality in haemodialysis patients. J Am Soc Nephrol. 2013;24:487–497. doi: 10.1681/ASN.2012080875. PubMed DOI PMC

Ok E, Asci G, Toz H, Ok ES, Kircelli F, Yilmaz M, et al. Mortality and cardiovascular events in online haemodiafiltration (OL-HDF) compared with high-flux dialysis: results from the Turkish OL-HDF study. Nephrol Dial Transplant. 2013;28:192–202. doi: 10.1093/ndt/gfs407. PubMed DOI

Peters SA, Bots ML, Canaud B, Davenport A, Grooteman MP, Kircelli F, et al. Haemodiafiltration and mortality in end-stage kidney disease patients: a pooled individual participant data analysis from four randomized controlled trials. Nephrol Dial Transplant. 2016;31:978–984. doi: 10.1093/ndt/gfv349. PubMed DOI

Tattersall JE, Ward RA. Online haemodiafiltration: definition, dose quantification and safety revisited. Nephrol Dial Transplant. 2013;28:542–550. doi: 10.1093/ndt/gfs530. PubMed DOI

Fischbach M, Terzic J, Menouer S, Dheu C, Seuge L, Zalosczic A. Daily on line haemodiafiltration promotes catch-up growth in children on chronic dialysis. Nephrol Dial Transplant. 2010;25:867–873. doi: 10.1093/ndt/gfp565. PubMed DOI

Fischbach M, Attal Y, Geisert J. Haemodiafiltration versus haemodialysis in children. Int J Pediatr Nephrol. 1984;5:151–154. PubMed

Fischbach M, Terzic J, Menouer S, Dheu C, Soskin S, Helmstetter A, et al. Intensified and daily haemodialysis in children might improve statural growth. Pediatr Nephrol. 2006;21:1746–1752. doi: 10.1007/s00467-006-0226-z. PubMed DOI

Querfeld U, Anarat A, Bayazit AK, Bakkaloglu AS, Bilginer Y, Caliskan S, et al. The cardiovascular comorbidity in children with chronic kidney disease (4C) study: objectives, design, and methodology. Clin J Am Soc Nephrol. 2010;5:1642–1648. doi: 10.2215/CJN.08791209. PubMed DOI PMC

Schaefer F, Doyon A, Azukaitis K, Bayazit A, Canpolat N, Duzova A, et al. Cardiovascular phenotypes in children with CKD: the 4C study. Clin J Am Soc Nephrol. 2017;12:19–28. doi: 10.2215/CJN.01090216. PubMed DOI PMC

Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Desvarieux M, et al. Mannheim intima-media thickness consensus. Cerebrovasc Dis. 2004;18:346–349. doi: 10.1159/000081812. PubMed DOI

Doyon A, Kracht D, Bayazit AK, Deveci M, Duzova A, Krmar RT, et al. Carotid artery intima-media thickness and distensibility in children and adolescents: reference values and role of body dimensions. Hypertension. 2013;62:550–556. doi: 10.1161/HYPERTENSIONAHA.113.01297. PubMed DOI

Kracht D, Shroff R, Baig S, Doyon A, Jacobi C, Zeller R, et al. Validating a new oscillometric device for aortic pulse wave velocity measurements in children and adolescents. Am J Hypertens. 2011;24:1294–1299. doi: 10.1038/ajh.2011.147. PubMed DOI

Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57:450–458. doi: 10.1016/0002-9149(86)90771-X. PubMed DOI

Khoury PR, Mitsnefes M, Daniels SR, Kimball TR. Age-specific reference intervals for indexed left ventricular mass in children. J Am Soc Echocardiogr. 2009;22:709–714. doi: 10.1016/j.echo.2009.03.003. PubMed DOI

Lai WW, Geva T, Shirali GS, Frommelt PC, Humes RA, Brook MM, et al. Guidelines and standards for performance of a paediatric echocardiogram: a report from the task force of the Paediatric Council of the American Society of echocardiography. J Am Soc Echocardiogr. 2006;19:1413–1430. doi: 10.1016/j.echo.2006.09.001. PubMed DOI

Wuhl E, Witte K, Soergel M, Mehls O, Schaefer F. Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions. J Hypertens. 2002;20:1995–2007. doi: 10.1097/00004872-200210000-00019. PubMed DOI

Eng CSY, Bhowruth D, Mayes M, Stronach L, Blaauw M, Barber A, et al. Assessing the hydration status of children with chronic kidney disease and on dialysis: a comparison of techniques. Nephrol Dial Transplant. 2017; PubMed

Wabel P, Moissl U, Chamney P, Jirka T, Machek P, Ponce P, et al. Towards improved cardiovascular management: the necessity of combining blood pressure and fluid overload. Nephrol Dial Transplant. 2008;23:2965–2971. doi: 10.1093/ndt/gfn228. PubMed DOI

K/DOQI clinical practice guidelines for Nutrition in Children with CKD. Am J Kidney Dis 2003, 42: S1–201. PubMed

Duranton F, Cohen G, De SR, Rodriguez M, Jankowski J, Vanholder R, et al. Normal and pathologic concentrations of uremic toxins. J Am Soc Nephrol. 2012;23:1258–1270. doi: 10.1681/ASN.2011121175. PubMed DOI PMC

Lisowska-Myjak B. Uremic toxins and their effects on multiple organ systems. Nephron Clin Pract. 2014;128:303–311. doi: 10.1159/000369817. PubMed DOI

Cheung AK, Rocco MV, Yan G, Leypoldt JK, Levin NW, Greene T, et al. Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study. J Am Soc Nephrol. 2006;17:546–555. doi: 10.1681/ASN.2005020132. PubMed DOI

Penne EL, van der Weerd NC, Blankestijn PJ, van den Dorpel MA, Grooteman MP, Nube MJ, et al. Role of residual kidney function and convective volume on change in beta2-microglobulin levels in haemodiafiltration patients. Clin J Am Soc Nephrol. 2010;5:80–86. doi: 10.2215/CJN.03340509. PubMed DOI PMC

Penne EL, van der Weerd NC, van den Dorpel MA, Grooteman MP, Levesque R, Nube MJ, et al. Short-term effects of online haemodiafiltration on phosphate control: a result from the randomized controlled convective transport study (CONTRAST) Am J Kidney Dis. 2010;55:77–87. doi: 10.1053/j.ajkd.2009.09.023. PubMed DOI

Penne EL, Visser L, van den Dorpel MA, van der Weerd NC, Mazairac AH, van Jaarsveld BC, et al. Microbiological quality and quality control of purified water and ultrapure dialysis fluids for online haemodiafiltration in routine clinical practice. Kidney Int. 2009;76:665–672. doi: 10.1038/ki.2009.245. PubMed DOI

Donauer J, Schweiger C, Rumberger B, Krumme B, Bohler J. Reduction of hypotensive side effects during online-haemodiafiltration and low temperature haemodialysis. Nephrol Dial Transplant. 2003;18:1616–1622. doi: 10.1093/ndt/gfg206. PubMed DOI

Daugirdas JT. Lower cardiovascular mortality with high-volume haemodiafiltration: a cool effect? Nephrol Dial Transplant. 2016;31:853–856. doi: 10.1093/ndt/gfv412. PubMed DOI

Grooteman MP, van den Dorpel MA, Bots ML, Penne EL, van der Weerd NC, Mazairac AH, et al. Effect of online haemodiafiltration on all-cause mortality and cardiovascular outcomes. J Am Soc Nephrol. 2012;23:1087–1096. doi: 10.1681/ASN.2011121140. PubMed DOI PMC

Shroff R, Bonthius M, Fischbach M, Edefonti A, Picca S, Jager K et al.. Paediatric dialysis practice across the EU - a survey from the EPDWG / ERA-EDTA Registries. 30[3], iii662. 2015.

Amato M, Montorsi P, Ravani A, Oldani E, Galli S, Ravagnani PM, et al. Carotid intima-media thickness by B-mode ultrasound as surrogate of coronary atherosclerosis: correlation with quantitative coronary angiography and coronary intravascular ultrasound findings. Eur Heart J. 2007;28:2094–2101. doi: 10.1093/eurheartj/ehm244. PubMed DOI

Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007;115:459–467. doi: 10.1161/CIRCULATIONAHA.106.628875. PubMed DOI

Szeto CC, Chow KM, Woo KS, Chook P, Ching-Ha KB, Leung CB, et al. Carotid intima media thickness predicts cardiovascular diseases in Chinese predialysis patients with chronic kidney disease. J Am Soc Nephrol. 2007;18:1966–1972. doi: 10.1681/ASN.2006101184. PubMed DOI

Delucchi A, Dinamarca H, Gainza H, Whitttle C, Torrealba I, Iniguez G. Carotid intima-media thickness as a cardiovascular risk marker in paediatric end-stage renal disease patients on dialysis and in renal transplantation. Transplant Proc. 2008;40:3244–3246. doi: 10.1016/j.transproceed.2008.03.126. PubMed DOI

Ferreira JP, Girerd N, Pannier B, Rossignol P, London GM. High pulse-wave velocity defines a very high cardiovascular risk cohort of Dialysis patients under age 60. Am J Nephrol. 2017;45:72–81. doi: 10.1159/000453338. PubMed DOI

Andre JL, Bourquard R, Guillemin F, Krier MJ, Briancon S. Final height in children with chronic renal failure who have not received growth hormone. Pediatr Nephrol. 2003;18:685–691. PubMed

Schaefer F. Daily online haemodiafiltration: the perfect ‘stimulus package’ to induce growth? Nephrol Dial Transplant. 2010;25:658–660. doi: 10.1093/ndt/gfp769. PubMed DOI

Zobrazit více v PubMed

ClinicalTrials.gov
NCT02063776

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...